scholarly journals Human-Factor Risk Mitigation in Outdoor Climbing Areas: Survey of Existing Policies in Regulated Climbing Areas

Author(s):  
Jourdan H. Meltzer ◽  
Joseph D. Forrester
Keyword(s):  
2015 ◽  
Vol 737 ◽  
pp. 428-431
Author(s):  
Ai Tao Zhou ◽  
Kai Wang ◽  
An Jin Liu ◽  
Hong Zhang

In order to reduce the human factor risk in drilling process, the author analyzed the primary reason of human factor risk in drilling process, selected twelve risk control measures and toke Delphi method to quantify the human factor risk mitigation capacity resulting from the selected risk control measures. The results shows that the human risk control measures exist in three tiers of effectiveness that with each tier being separated by nearly an order of magnitude, and the types of most risk mitigation are risk codes such as injury by machine, fall from height, contact with harmful material. And the most minimally risk mitigation ones are muscle strain, fire explosion and other types. Finally these data, which will be valuable for drilling companies to strategically allocate limited resources to their safety management plan, can evaluate the expected effectiveness resulting from risk control measures.


2021 ◽  
Vol 55 (5) ◽  
pp. 31-39
Author(s):  
E.A. Praskurnichiy ◽  
◽  
V.P. Kulichenko ◽  
E.I. Polubentseva ◽  
I.V. Ivanov ◽  
...  

The authors examined the current conception of flight safety, medical risks management, prevention of accidents due to the human factor, and updated flight safety definition. Health and physiological examinations within the pilot medical certification procedure are, unconditionally, important determinants of flight safety. However, maintenance and realization of key professional qualities confront a number of extra- and intersystem factors that can create some level of risk. Mitigation of these risks and medical risks management should be taken as the basis for preventing aviation accidents caused by the human factor.


2016 ◽  
Vol 6 (1) ◽  
pp. 33-38 ◽  
Author(s):  
Isaac Munene

Abstract. The Human Factors Analysis and Classification System (HFACS) methodology was applied to accident reports from three African countries: Kenya, Nigeria, and South Africa. In all, 55 of 72 finalized reports for accidents occurring between 2000 and 2014 were analyzed. In most of the accidents, one or more human factors contributed to the accident. Skill-based errors (56.4%), the physical environment (36.4%), and violations (20%) were the most common causal factors in the accidents. Decision errors comprised 18.2%, while perceptual errors and crew resource management accounted for 10.9%. The results were consistent with previous industry observations: Over 70% of aviation accidents have human factor causes. Adverse weather was seen to be a common secondary casual factor. Changes in flight training and risk management methods may alleviate the high number of accidents in Africa.


1991 ◽  
Vol 36 (8) ◽  
pp. 730-730
Author(s):  
No authorship indicated
Keyword(s):  

1998 ◽  
Vol 79 (01) ◽  
pp. 104-109 ◽  
Author(s):  
Osamu Takamiya

SummaryMurine monoclonal antibodies (designated hVII-B101/B1, hVIIDC2/D4 and hVII-DC6/3D8) directed against human factor VII (FVII) were prepared and characterized, with more extensive characterization of hVII-B101/B1 that did not bind reduced FVIIa. The immunoglobulin of the three monoclonal antibodies consisted of IgG1. These antibodies did not inhibit procoagulant activities of other vitamin K-dependent coagulation factors except FVII and did not cross-react with proteins in the immunoblotting test. hVII-DC2/D4 recognized the light chain after reduction of FVIIa with 2-mercaptoethanol, and hVIIDC6/3D8 the heavy chain. hVII-B101/B1 bound FVII without Ca2+, and possessed stronger affinity for FVII in the presence of Ca2+. The Kd for hVII-B101/B1 to FVII was 1.75 x 10–10 M in the presence of 5 mM CaCl2. The antibody inhibited the binding of FVII to tissue factor in the presence of Ca2+. hVII-B101/B1 also inhibited the activation of FX by the complex of FVIIa and tissue factor in the presence of Ca2+. Furthermore, immunoblotting revealed that hVII-B101/B1 reacted with non-reduced γ-carboxyglutaminic acid (Gla)-domainless-FVII and/or FVIIa. hVII-B101/B1 showed a similar pattern to that of non-reduced proteolytic fragments of FVII by trypsin with hVII-DC2/D4 on immunoblotting test. hVII-B101/B1 reacted differently with the FVII from the dysfunctional FVII variant, FVII Shinjo, which has a substitution of Gln for Arg at residue 79 in the first epidermal growth factor (1st EGF)-like domain (Takamiya O, et al. Haemosta 25, 89-97,1995) compared with normal FVII, when used as a solid phase-antibody for ELISA by the sandwich method. hVII-B101/B1 did not react with a series of short peptide sequences near position 79 in the first EGF-like domain on the solid-phase support for epitope scanning. These results suggested that the specific epitope of the antibody, hVII-B101/B1, was located in the three-dimensional structure near position 79 in the first EGF-like domain of human FVII.


Sign in / Sign up

Export Citation Format

Share Document